Jonathan E. Lim, President, CEO at HALOZYME THERAPEUTICS INC (HALO), sold 12,200 shares at $8.54 ($105K) on 2007-08-31, disclosed to the SEC on 2007-08-31.
Scheduled sale ($105k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.30 | 270 | $2K | 2.1% |
| 2 | $8.31 | 105 | $873 | 0.8% |
| 3 | $8.34 | 200 | $2K | 1.6% |
| 4 | $8.35 | 400 | $3K | 3.2% |
| 5 | $8.40 | 200 | $2K | 1.6% |
| 6 | $8.42 | 200 |
| $2K |
| 1.6% |
| 7 | $8.46 | 40 | $338 | 0.3% |
| 8 | $8.47 | 260 | $2K | 2.1% |
| 9 | $8.48 | 600 | $5K | 4.9% |
| 10 | $8.49 | 100 | $849 | 0.8% |
| 11 | $8.50 | 1,025 | $9K | 8.3% |
| 12 | $8.51 | 100 | $851 | 0.8% |
| 13 | $8.52 | 80 | $682 | 0.7% |
| 14 | $8.53 | 580 | $5K | 4.7% |
| 15 | $8.54 | 700 | $6K | 5.7% |
| 16 | $8.55 | 200 | $2K | 1.6% |
| 17 | $8.56 | 100 | $856 | 0.8% |
| 18 | $8.57 | 220 | $2K | 1.8% |
| 19 | $8.58 | 220 | $2K | 1.8% |
| 20 | $8.59 | 1,100 | $9K | 9.0% |
| 21 | $8.60 | 500 | $4K | 4.1% |
| 22 | $8.61 | 100 | $861 | 0.8% |
| 23 | $8.62 | 1,400 | $12K | 11.5% |
| 24 | $8.63 | 400 | $3K | 3.3% |
| 25 | $8.64 | 300 | $3K | 2.5% |
| 26 | $8.66 | 200 | $2K | 1.7% |
| 27 | $8.67 | 300 | $3K | 2.5% |
| 28 | $8.68 | 700 | $6K | 5.8% |
| 29 | $8.69 | 1,600 | $14K | 13.3% |
| Total | $8.57 avg | 12,200 | $105K | 100% |
| Filing → |
| ERAS | BUY | 2023-06-08 | $275K | — | Filing → |
| ERAS | BUY | 2023-03-28 | $284K | — | Filing → |
| ERAS | BUY | 2023-01-10 | $232K | — | Filing → |